MASNERI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 901
EU - Europa 479
AS - Asia 179
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.564
Nazione #
US - Stati Uniti d'America 898
IT - Italia 118
CN - Cina 103
PL - Polonia 100
UA - Ucraina 87
DE - Germania 55
HK - Hong Kong 42
FI - Finlandia 38
SG - Singapore 25
GB - Regno Unito 23
IE - Irlanda 17
FR - Francia 10
SE - Svezia 10
ES - Italia 9
VN - Vietnam 8
RU - Federazione Russa 4
CA - Canada 3
RO - Romania 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 1.564
Città #
Fairfield 132
Warsaw 100
Ashburn 93
Houston 86
Jacksonville 72
Woodbridge 71
Seattle 55
Ann Arbor 53
Chandler 49
Hong Kong 42
New York 40
Wilmington 40
Cambridge 39
Beijing 36
Princeton 36
Brescia 34
Helsinki 32
Dublin 17
Dearborn 14
Nanjing 12
Shanghai 12
Singapore 12
Milan 11
Des Moines 9
San Diego 9
Dong Ket 8
Bergamo 7
Changsha 6
Tianjin 5
Boardman 4
Jinan 4
San Francisco 4
Santiago De Compostela 4
Guangzhou 3
Hebei 3
Jiaxing 3
Lancaster 3
London 3
Mariano Comense 3
Nanchang 3
Napoli 3
Neustadt 3
Redwood City 3
Rome 3
Sevilla 3
Shenyang 3
Brooklyn 2
Brussels 2
Haikou 2
Lanzhou 2
New Bedfont 2
North York 2
Qingdao 2
Segrate 2
Todi 2
Whitley Bay 2
Baotou 1
Berlin 1
Bratislava 1
Brno 1
Castiglione Delle Stiviere 1
Dallas 1
Darfo 1
Falkenstein 1
Fremont 1
Fuzhou 1
Hangzhou 1
Islington 1
Kunming 1
Lappeenranta 1
Lincoln 1
Los Angeles 1
Mandurah 1
Melbourne 1
Norwalk 1
Nottingham 1
Omsk 1
Parla 1
Passirano 1
Phoenix 1
Redmond 1
St Petersburg 1
Taizhou 1
Toronto 1
Toscolano-Maderno 1
Verolanuova 1
Verona 1
Weimar 1
Totale 1.239
Nome #
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 146
CRI DU CHAT INDUCED PLURIPOTENT STEM CELLS: NEW FRONTIERS IN DISEASE UNDERSTANDING 137
CRI DU CHAT INDUCED PLURIPOTENT STEM CELLS: NEW FRONTIERS IN DISEASE UNDERSTANDING 132
Generation of induced pluripotent stem cells (iPSCs) from patient with Cri du Chat Syndrome 121
Correlation of bone marrow abnormalities, peripheral lymphocyte subsets and clinical features in uncomplicated common variable immunodeficiency (CVID) patients 112
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment 106
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 80
ALTERED B AND T LYMPHOCYTE HOMEOSTASIS IN THE BONE MARROW AND THE PERIPHERY CORRELATES WITH CLINICAL FINDINGS IN COMMON VARIABLE IMMUNODEFICIENCY (CVID) 76
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 76
Biomarkers and precision therapy for primary immunodeficiencies: an in vitro study based on induced pluripotent stem cells (iPSCs) from patients 71
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 71
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 70
CASE REPORT: IDENTIFICATION OF A PATIENT WITH FAMILIAR MUTATIONS AFFECTING BOTH WASP AND FOXP3 GENES 67
WASP-WIP DEFICIENCIES: NEW INSIGHTS IN WASP-WIP INTERACTION 65
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 55
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene 53
Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene 50
PAX1 is essential for development and function of the human thymus 44
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 36
Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene 20
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 18
Totale 1.606
Categoria #
all - tutte 7.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020455 0 6 7 43 48 67 52 52 43 80 28 29
2020/2021406 17 47 13 45 31 69 12 40 31 46 26 29
2021/2022191 14 17 8 16 0 11 11 12 9 31 25 37
2022/2023150 19 4 9 5 12 39 0 15 27 2 8 10
2023/2024239 16 1 27 15 26 53 8 12 46 6 2 27
2024/20254 1 3 0 0 0 0 0 0 0 0 0 0
Totale 1.606